Document detail
ID

doi:10.1186/s12913-024-11071-3...

Author
Haslam, Alyson Prasad, Vinay
Langue
en
Editor

BioMed Central

Category

Medicine & Public Health

Year

2024

listing date

6/5/2024

Keywords
offered treated covid hospitals services trials top centers
Metrics

Abstract

Background The economic and health burden of COVID-19 has transformed the healthcare system in the US.

Hospitals have adapted to the heterogeneity in long COVID symptoms, and the sheer number of people affected by this condition, by building long COVID centers and programs.

Objective We sought to describe characteristics, services, and clinical trials of long COVID centers at top US hospitals.

Design Cross-sectional analysis.

Participants Long COVID treatment programs or centers at top US hospitals.

Exposures Frequency of long COVID centers, eligibility for being treated, the services they provide, specialist to whom the patients may be referred, and the long COVID clinical trials in which these hospitals participate.

Findings Most top hospitals in the US ( n  = 43/50; 86%) offer long COVID services.

65% (28/43) did not describe the services provided.

12 (28%) required a referral from a primary care physician.

The most common services were meeting with a team member ( n  = 20; 47%), ordering lab and/or radiology services ( n  = 8; 18.6%), and administering a physical exam ( n  = 7; 16%).

7 (16%) centers/programs treated only adults; 5 (12%) treated both adults and children, and 31 (72%) did not specify.

The most common specialists described were psychology ( n  = 25; 58%), neurology ( n  = 25; 58%), and pulmonary ( n  = 24; 56%).

Sixty-three trials (of 134 long COVID clinical trials) had at least one top hospital listed as a study site.

The median number of clinical trials that each hospital sponsored or was a study site was 2 (interquartile range: 1, 3).

Conclusions and relevance We find that services offered at long COVID clinics at top hospitals in the US often include meeting with a team member and referrals to a wide range of specialists.

The diversity in long COVID services offered parallels the diversity in long COVID symptoms, suggesting a need for better consensus in developing and delivering treatment.

Haslam, Alyson,Prasad, Vinay, 2024, Long COVID clinics and services offered by top US hospitals: an empirical analysis of clinical options as of May 2023, BioMed Central

Document

Open

Share

Source

Articles recommended by ES/IODE AI

Should we consider Systemic Inflammatory Response Index (SIRI) as a new diagnostic marker for rectal cancer?
inflammation rectal surgery overall survival complication significantly diagnostic value cancer rectal 38 siri